Neupro® (Restless Legs Syndrome)

Europe

In Europe, Neupro® (rotigotine transdermal patch) is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.

USA

In the US, Neupro® (Rotigotine Transdermal System) is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.

Prescribing information USA